A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management

Gadd, 1993, Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma, Ann Surg, 218, 705, 10.1097/00000658-199312000-00002 Morton, 1973, Surgical resection and adjunctive immunotherapy for selected patients with multiple pulmonary metastases, Ann Surg, 178, 360, 10.1097/00000658-197309000-00016 Wilkins, 1961, The surgical management of metastatic neoplasms in the lung, J Thorac Cardiovasc Surg, 42, 298, 10.1016/S0022-5223(20)31919-X Ambiru, 1998, Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma, Cancer, 82, 274, 10.1002/(SICI)1097-0142(19980115)82:2<274::AID-CNCR5>3.0.CO;2-R Fong, 1997, Liver resection for colorectal metastases, J Clin Oncol, 15, 938, 10.1200/JCO.1997.15.3.938 Fong, 1999, Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases, Ann Surg, 230, 309, 10.1097/00000658-199909000-00004 Inoue, 2000, Surgery for pulmonary metastases from colorectal carcinoma, Ann Thorac Surg, 70, 380, 10.1016/S0003-4975(00)01417-X Irshad, 2001, Pulmonary metastases from colorectal cancer: 25years of experience, Can J Surg, 44, 217 Nordlinger, 1996, Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie, Cancer, 77, 1254, 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I Nordlinger, 1987, Surgical resection of liver metastases from colo-rectal cancers, Int Surg, 72, 70 Nordlinger, 1994, Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie, J Clin Oncol., 12, 1491, 10.1200/JCO.1994.12.7.1491 Reddy, 2007, Simultaneous resections of colorectal cancer and synchronous liver metastases: A multi-institutional analysis, Ann Surg Oncol, 14, 3481, 10.1245/s10434-007-9522-5 Rena, 2002, Pulmonary resection for metastases from colorectal cancer: Factors influencing prognosis. Twenty-year experience, Eur J Cardiothorac Surg., 21, 906, 10.1016/S1010-7940(02)00088-X Sakamoto, 2001, Pulmonary resection for metastases from colorectal cancer, Chest, 119, 1069, 10.1378/chest.119.4.1069 Hellman, 1995, Oligometastases, J Clin Oncol, 13, 8, 10.1200/JCO.1995.13.1.8 National comprehensive cancer network (NCCN) clinical practice guidelines in oncology. Colon Cancer. Version 2.2017.2017. McDonald, 1994, Pulmonary resection for metastatic breast cancer, Ann Thorac Surg, 58, 1599, 10.1016/0003-4975(94)91639-X Staren, 1992, Pulmonary resection for metastatic breast cancer, Arch Surg, 127, 1282, 10.1001/archsurg.1992.01420110024006 Hoyer, 2006, Phase II study on stereotactic body radiotherapy of colorectal metastases, Acta Oncol (Madr), 45, 823, 10.1080/02841860600904854 Méndez Romero, 2006, Stereotactic body radiation therapy for primary and metastatic liver tumors:A single institution phase i-ii study, Acta Oncol (Madr), 45, 831, 10.1080/02841860600897934 Rusthoven, 2009, Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases, J Clin Oncol, 27, 1572, 10.1200/JCO.2008.19.6329 Scorsetti, 2013, Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial, Int J Radiat Oncol Biol Phys, 86, 336, 10.1016/j.ijrobp.2012.12.021 Chang, 2011, Stereotactic body radiotherapy for colorectal liver metastases, Cancer, 117, 4060, 10.1002/cncr.25997 Joo, 2017, Local control outcomes using stereotactic body radiation therapy for liver metastases from colorectal cancer, Int J Radiat Oncol Biol Phys, 99, 876, 10.1016/j.ijrobp.2017.07.030 McPartlin, 2017, Long-term outcomes of phase 1 and 2 studies of SBRT for hepatic colorectal metastases, Int J Radiat Oncol Biol Phys, 99, 388, 10.1016/j.ijrobp.2017.04.010 Stinauer, 2011, Stereotactic body radiation therapy for melanoma and renal cell carcinoma: Impact of single fraction equivalent dose on local control, Radiat Oncol, 6, 34, 10.1186/1748-717X-6-34 Park, 2008, Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy, Int J Radiat Oncol Biol Phys, 70, 847, 10.1016/j.ijrobp.2007.10.059 Ahmed, 2016, Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes after stereotactic body radiation therapy, Int J Radiat Oncol Biol Phys, 95, 1399, 10.1016/j.ijrobp.2016.03.050 Klement, 2017, Stereotactic body radiotherapy for oligo-metastatic liver disease—Influence of pre-treatment chemotherapy and histology on local tumor control, Radiother Oncol, 123, 227, 10.1016/j.radonc.2017.01.013 Hong, 2017, Phase II study of proton-based stereotactic body radiation therapy for liver metastases: Importance of tumor genotype, J Natl Cancer Inst, 109(1) Milano, 2008, A prospective pilot study of curative−intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions, Cancer, 112, 650, 10.1002/cncr.23209 Milano, 2012, Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study, Int J Radiat Oncol Biol Phys, 83, 878, 10.1016/j.ijrobp.2011.08.036 Scorsetti, 2016, Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer, Breast, 26, 11, 10.1016/j.breast.2015.12.002 Gomez, 2016, Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer without progression after first-line systemic therapy: A multicentre, randomised, controlled, phase 2 study, Lancet Oncol, 17, 1672, 10.1016/S1470-2045(16)30532-0 Iyengar P, Wardak Z, Gerber DE, et al: Consolidative radiotherapy for limited metastatic non–small-cell lung cancer: A phase 2 randomized clinical trial. JAMA oncologyOncol. 2017: e173501-e173501. Palma, 2012, Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial, BMC Cancer, 12, 305, 10.1186/1471-2407-12-305 Demaria, 2015, Role of local radiation therapy in cancer immunotherapy, JAMA Oncol, 1, 1325, 10.1001/jamaoncol.2015.2756 Ng, 2016, Radiation therapy and the abscopal effect: A concept comes of age, Ann Transl Med, 4, 118, 10.21037/atm.2016.01.32 Postow, 2012, Immunologic correlates of the abscopal effect in a patient with melanoma, N Engl J Med, 366, 925, 10.1056/NEJMoa1112824 Golden, 2013, An abscopal response to radiation and ipilimumab in a patient with metastatic non–small cell lung cancer, Cancer Immunol Res, 1, 365, 10.1158/2326-6066.CIR-13-0115 Bang, 2017, Multicenter evaluation of the tolerability of combined treatment with PD-1 and CTLA-4 immune checkpoint inhibitors and palliative radiation therapy, Int J Radiat Oncol Biol Phys, 98, 344, 10.1016/j.ijrobp.2017.02.003 Hiniker, 2016, A prospective clinical trial combining radiation therapy with systemic immunotherapy in metastatic melanoma, Int J Radiat Oncol Biol Phys, 96, 578, 10.1016/j.ijrobp.2016.07.005 Tang, 2017, Ipilimumab with stereotactic ablative radiation therapy: Phase I results and immunologic correlates from peripheral T Cells, Clin Cancer Res, 23, 1388, 10.1158/1078-0432.CCR-16-1432 Luke, 2018, Safety and clinical activity of pembrolizumab and multisite stereotactic body radiotherapy in patients with advanced solid tumors, J Clin Oncol, 36, 1611, 10.1200/JCO.2017.76.2229 Dewan, 2009, Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody, Clin Cancer Res, 15, 5379, 10.1158/1078-0432.CCR-09-0265 Chandra, 2015, A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab, Oncoimmunology, 4, 10.1080/2162402X.2015.1046028 Young, 2016, Optimizing timing of immunotherapy improves control of tumors by hypofractionated radiation therapy, PLoS One, 11, 10.1371/journal.pone.0157164 Dovedi, 2014, Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade, Cancer Res, 74, 5458, 10.1158/0008-5472.CAN-14-1258 Dovedi, 2017, Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 blockade, Clin Cancer Res, 23, 5514, 10.1158/1078-0432.CCR-16-1673 Antonia, 2017, Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer, N Engl J Med, 377, 1919, 10.1056/NEJMoa1709937 Wang, 2017, Suppression of Type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy, Cancer Res, 77, 839, 10.1158/0008-5472.CAN-15-3142